BATTERSEA BIOTECH Trademark

Serial Number: 87579575

BATTERSEA BIOTECH is a trademark filed by Battersea Biotech, LLC on August 22, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

5

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

9

Class 9 - Computers & Electronics

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

42

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

44

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Battersea Biotech, LLC

329 Oyster Point Boulevard, Floor 3
South San Francisco, CA 94080

Entity Type: 16

Legal Representation

Attorney of Record

Chelsea E. Carbone

142 trademarks filed View all →

Trademark Details

Filing Date

August 22, 2017

Registration Date

Not Registered

Goods & Services

Scientific apparatus for priming and stimulating particular cells of the immune system for the treatment of cancer and autoimmune diseases and disorders

Pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of cancer and tumors via tumor antigen reactive T cells and Natural Killer cells; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cells for medical or clinical use; kits comprised of cells and pharmaceuticals for medical or clinical use; pharmaceuticals for use in the treatment of infectious diseases and in cellular transplants; pharmaceutical preparations for immunotherapy, including T cell and Natural Killer cell therapy

Medical treatment services, namely, administration of gene therapy; medical and therapeutic services, namely, immunotherapy services comprising harvesting, transducing, or otherwise manipulating ex-vivo and re-administering blood cells

Research and development of pharmaceuticals for the treatment of cancer and immune system-related diseases and disorders; clinical research in the field of cancer treatment and treatment of disorders related to the immune system; medical research services in the field of cancer, namely, priming and stimulating T cells and Natural Killer cells for research purposes